May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
Variants of the CFH Gene, Smoking and the Risk of Early and Late Age-Related Maculopathy
Author Affiliations & Notes
  • A. Farwick
    University Muenster, Muenster, Germany
    Institute of Epidemiology and Social Medicine,
  • D. Pauleikhoff
    Ophthalmology Department, St. Franziskus Hospital, Muenster, Germany
  • M. Stoll
    University Muenster, Muenster, Germany
    Leibniz-Institute of Atherosclerosis Research,
  • H. W. Hense
    University Muenster, Muenster, Germany
    Institute of Epidemiology and Social Medicine,
  • Footnotes
    Commercial Relationships A. Farwick, None; D. Pauleikhoff, None; M. Stoll, None; H.W. Hense, None.
  • Footnotes
    Support HE 2293/5-1/2/3
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1154. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Farwick, D. Pauleikhoff, M. Stoll, H. W. Hense; Variants of the CFH Gene, Smoking and the Risk of Early and Late Age-Related Maculopathy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1154. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: Numerous genetic variants within the Complement Factor H (CFH) gene have been shown to be associated with established age-related macular degeneration (AMD), i.e. geographic atrophy (GA) or neovascularisation (CNV). Less is known about the genetic associations with maculopathy (ARM), i.e. drusen and/or pigment abnormalities, the interaction between the different variants on risk, and about potential environmental modifiers.

Methods:: We investigated these questions in a large cohort of patients with ARM (N = 440), AMD (n = 278) and controls (n = 177) from the Muenster Aging and Retina Study (MARS) in which all phenotypes were assigned after standardised grading of digital fundus photos. We genotyped all patients for CFH-SNPs: rs1061170, rs2274700 and rs1292487.

Results:: We observed that both, rs10611770 and rs2274700, significantly increased the risk of ARM in heterozygous (each OR = 1.9) and homozygous patients (OR 5.6 and 4.3, respectively). The AMD risk was substantially raised: OR = 2.0 and 1.9 for heterozygous 6.9 and 5.9, resp., in homozygous patients. Both SNPs were more strongly associated with CNV than GA, and only for CNV we found a significant risk increment due to smoking (homozygous smokers OR = 7.9 and 13.7, resp.; p < 0.0001). Furthermore, patients homozygous for both risk variants (30% of ARM and 35.4% of AMD) showed an 8.2-fold risk of ARM and 10.9 times higher risk of AMD compared to people carrying only the wild-types. By contrast, rs1292487 showed a significant and clear protective effect on both ARM and AMD (ORs from 0.73 to 0.19), in particular among the homozygous.

Conclusions:: Our results indicate that several CFH variants are associated with early and late disorders of the ageing macula. The association is particularly pronounced for the occurrence of CNV, and smoking seems to confer substantial risk increments. The two risk variants act in a synergistical way and generate a cumulative risk of AMD. However, there are also less common variants which confer protection against the ageing disorders of the macula.

Keywords: age-related macular degeneration • genetics 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.